Thibault Boutherin
Stock Analyst at Morgan Stanley
(0.59)
# 4,136
Out of 5,154 analysts
4
Total ratings
50%
Success rate
-11.74%
Average return
Main Sectors:
Stocks Rated by Thibault Boutherin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALVO Alvotech | Upgrades: Overweight | $14 | $4.01 | +249.13% | 2 | Oct 14, 2025 | |
| NVO Novo Nordisk | Downgrades: Underweight | $59 → $47 | $38.58 | +21.82% | 1 | Sep 29, 2025 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Equal-Weight | $10 | $31.05 | -67.79% | 1 | May 25, 2023 |
Alvotech
Oct 14, 2025
Upgrades: Overweight
Price Target: $14
Current: $4.01
Upside: +249.13%
Novo Nordisk
Sep 29, 2025
Downgrades: Underweight
Price Target: $59 → $47
Current: $38.58
Upside: +21.82%
Teva Pharmaceutical Industries
May 25, 2023
Initiates: Equal-Weight
Price Target: $10
Current: $31.05
Upside: -67.79%